MAT WAIVER Information

New Jersey ACEP is committed to serving our communities and promoting rapid access to buprenorphine and other appropriate treatments for patients struggling with opioid use disorder.  NJ-ACEP recognizes the increasing mortality from opioid overdose and supports buprenorphine initiation in the emergency department for the treatment of opioid use disorder.  We strongly encourage all emergency departments in New Jersey to integrate buprenorphine into their patient treatment options. We will work to promote buprenorphine education, mentorship, and transition of care for all emergency physicians in the state.

              

Waiver trainings: 

Physicians, residents, APRNs, PAs and medical students from all over the US are eligible for the course. 

Given the recent release of the Department of Health and Human Services (HHS) new Practice Guidelines on prescribing buprenorphine for opioid use disorder (HHS release here, and Practice Guidelines here) we will be updating the training being provided.

The course content will now review all the information needed to use/prescribe buprenorphine in and ED and faculty will walk attendees through the process of registering with SAMHSA to get prescribing privileges. The updated duration is now approx. 120 mins and CME will be provided.

Tuesday, May 11th from 10 am - 12 pm

Thursday, June 10th from 5 pm - 7 pm

Wednesday, July 21st from 9 am -11 am

Tuesday, October 5th from 5 pm - 7 pm

 

PCSS Funding information:

DATA 2000 Sponsor: American Academy of Addiction Psychiatry

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human ServicesÍž nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

PCSS website link: www.pcssNOW.org

Contact information: [email protected]